Binge Eating Disorder Clinical Trials 2023

Browse 20 Binge Eating Disorder Medical Studies Across 12 Cities

3 Phase 3 Trial · 20 Binge Eating Disorder Clinics

Reviewed by Michael Gill, B. Sc.
Image of Drexel University, Stratton Hall in Philadelphia, United States.

MABT: Mindful Awarenessfor Bulimia

18 - 70
All Sexes
Philadelphia, PA
This trial is designed to study the independent and combined effects of four components of mindfulness-based behavioral therapy on eating pathology. The four components are Mindful Awareness, Distress Tolerance, Emotion Modulation, and Values-Based Decision Making. The trial will compare the efficacy of each component when used alone and in combination with standard behavioral treatment for bulimia nervosa and binge eating disorder. The primary aim of the study is to evaluate the independent efficacy of each treatment component on eating pathology. Secondary aims are to test the hypotheses that the efficacy of each component is moderated by related baseline deficits in self-regulation, and to quantify the component interaction
Waitlist Available
Has No Placebo
Drexel University, Stratton Hall
10 Binge Eating Disorder Clinical Trials Near Me
Top Hospitals for Binge Eating Disorder Clinical Trials
Image of Drexel University, Stratton Hall in Pennsylvania.
Drexel University, Stratton Hall
Philadelphia
3Active Trials
5All Time Trials for Binge Eating Disorder
2018First Binge Eating Disorder Trial
Image of Yale Department of Psychiatry in Connecticut.
Yale Department of Psychiatry
New Haven
3Active Trials
4All Time Trials for Binge Eating Disorder
2007First Binge Eating Disorder Trial
Image of Lindner Center of HOPE in Ohio.
Lindner Center of HOPE
Mason
2Active Trials
8All Time Trials for Binge Eating Disorder
2006First Binge Eating Disorder Trial
Image of Drexel University in Pennsylvania.
Drexel University
Philadelphia
1Active Trials
6All Time Trials for Binge Eating Disorder
2015First Binge Eating Disorder Trial
Image of Yale Medical School Department of Psychiatry in Connecticut.
Yale Medical School Department of Psychiatry
New Haven
1Active Trials
1All Time Trials for Binge Eating Disorder
2022First Binge Eating Disorder Trial
Top Cities for Binge Eating Disorder Clinical Trials
Image of New Haven in Connecticut.
New Haven
4Active Trials
Yale Department of PsychiatryTop Active Site
Binge Eating Disorder Clinical Trials by Phase of TrialBinge Eating Disorder Clinical Trials by Age Group
< 18 Binge Eating Disorder Clinical Trials
1Active Binge Eating Disorder Clinical Trials
Most Recent Binge Eating Disorder Clinical TrialsTop Treatments for Binge Eating Disorder Clinical Trials
Treatment Name
Active Binge Eating Disorder Clinical Trials
All Time Trials for Binge Eating Disorder
First Recorded Binge Eating Disorder Trial
LDX
2
2
2019
Base self-help CBT program plus Just-in-time, adaptive interventions (JITAIs)
1
1
2022
Behavioral Therapy for Eating Disorders
1
2
2020
Cognitive behavioral therapy guided self help (CBTgsh)
1
1
2022
Morning light version+ Melatonin
1
1
2021
Recently Completed Studies with FDA Approved Treatments for Binge Eating Disorder
Treatment
Year
Sponsor
ACT-539313
2021
Idorsia Pharmaceuticals Ltd.
Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination
2018
Yale University
NB Medication (on-going from acute treatment)
2017
Yale University
NB medication (Naltrexone Bupropion combination)
2017
Yale University
NB medication (Naltrexone Bupropion combination)
2017
Yale University

What Are Binge Eating Disorder Clinical Trials?

Binge eating disorder, or BED, is a life-threatening, treatable disorder characterized by recurrent binge eating episodes. People struggling with binge eating disorder eat large quantities of food quickly and to the point of feeling uncomfortably full. These episodes occur even when the affected individual is not feeling physically hungry and cause feelings of guilt and disgust, resulting in some form of compensatory measure. People can use laxatives, self-induced vomiting, or excessive exercise to counter binge eating.

BED is one of the newest additions to eating disorders in the DSM-5. Binge eating disorder clinical trials can help inform a care plan and teach healthcare professionals more about this disorder. BED is diagnosed by recurrent binge eating episodes, a lack of control over eating impulses, discretely consuming large quantities of food, and compensatory behaviors.

People with BED are also concerned with their body weight and shape and make lifestyle schedules to accommodate their binge sessions. They are at risk of developing clinical obesity and struggle with weight cycling and weight stigma.

Why Is Binge Eating Disorder Being Studied Through Clinical Trials?

According to Eating Recovery Center, 8% of U.S. adults suffer from binge eating disorder in their lifetime, making it the most common eating disorder in the country. People who are at risk of BED can inherit this disorder. More than half of binge eating disorder patients have comorbid anxiety disorders, and almost half of them have a comorbid mood disorder.

Binge eating disorder clinical trials can help medical and mental health professionals learn more about this condition and develop novel ways to prevent, screen, and treat it. These trials can also help develop future studies and develop more effective drugs and therapies to treat the disorder.

What Are The Types of Treatments Available for Binge Eating Disorder?

The supportive treatment for binge eating disorder depends on the severity and causes of the disorder and individual goals. For instance, the treatment plan might target mental health issues causing BED, excessive binge eating behaviors, body image issues, excess weight, or different combinations of these treatments.

People with binge eating disorders can receive different therapy, such as cognitive behavior therapy, dialectical behavior therapy, medication, interpersonal psychotherapy, and weight loss therapy. The therapist might carry out these treatments in a group setting, individual setting, or on a self-help basis.

Some people with BED might need a singular therapy form, while others require different combinations to combat their disorder. A mental health professional will guide the individual with BED in selecting a custom treatment plan. Moreover, new binge eating disorder clinical trials can also help develop new medications and supportive treatment plans.

What Are Some Recent Breakthrough Clinical Trials for Binge Eating Disorder?

Here are two recent binge eating disorder clinical trials:

2017: A Randomized Clinical Trial to Test the Efficacy of Lixdexamfetamine in Adults with Moderate to Severe BED – This trial successfully established the efficacy of lisdexamfetamine as a long-term treatment for binge eating disorder. The results showed the risk of binge eating and relapsing was lower in participants who continued lisdexamfetamine for six months.

2021: A Randomized Clinical Trial to Assess the Safety & Efficacy of Dasotraline in Adults with BED – This fixed-dose, placebo-controlled clinical trial continued for 12 weeks and discovered that treating patients with binge eating disorder with six mg/d of dasotraline proved to be effective in reducing binge eating days per week. The medication improved binge eating-related compulsive behaviors and obsessive thoughts.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: September 14th, 2023

References1 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. https://pubmed.ncbi.nlm.nih.gov/115569412 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. https://pubmed.ncbi.nlm.nih.gov/115569413 Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. doi: 10.1016/s1389-9457(00)00065-4. https://pubmed.ncbi.nlm.nih.gov/114382464 Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. https://pubmed.ncbi.nlm.nih.gov/114382465 Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985 Sep;10(3):141-6. https://pubmed.ncbi.nlm.nih.gov/40532616 Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993 Jun;88(6):791-804. https://pubmed.ncbi.nlm.nih.gov/83299707 Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993 Jun;88(6):791-804. doi: 10.1111/j.1360-0443.1993.tb02093.x. https://pubmed.ncbi.nlm.nih.gov/83299708 Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord. 1994 Dec;16(4):363-70. https://pubmed.ncbi.nlm.nih.gov/78664159 Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 1;61(3):348-58. doi: 10.1016/j.biopsych.2006.03.040. Epub 2006 Jul 3. Erratum In: Biol Psychiatry. 2012 Jul 15;72(2):164. https://pubmed.ncbi.nlm.nih.gov/1681532210 Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 1;61(3):348-58. Epub 2006 Jul 3. Erratum in: Biol Psychiatry. 2012 Jul 15;72(2):164. https://pubmed.ncbi.nlm.nih.gov/16815322